Literature DB >> 12528713

Persistent IGF-I overexpression in skeletal muscle transiently enhances DNA accretion and growth.

Marta L Fiorotto1, Robert J Schwartz, M Craig Delaughter.   

Abstract

Adult transgenic mice with muscle-specific overexpression of insulin-like growth factor (IGF)-I have enlarged skeletal muscles. In this study, we; 1) characterized the development of muscle hypertrophy with respect to fiber type, age, and sex; 2) determined the primary anabolic process responsible for development of hypertrophy; and 3) identified secondary effects of muscle hypertrophy on body composition. Transgene expression increased with age and was present only in fibers expressing type IIB fast myosin heavy chain. Muscle masses were greater by 5 wk of age, and by 10 wk of age the differences were maximal despite continued transgene expression. Total DNA and RNA contents of the gastrocnemius muscle were greater for transgenic mice than for nontransgenic littermates. The differences were maximal by 5 wk of age and preceded the increase in protein mass. The accelerated protein deposition ceased when the protein/DNA ratio attained the same value as in nontransgenic controls. Despite localization of IGF-I expression to muscle without changes in plasma IGF-I concentrations, genotype also modified the normal age and sex effects on fat deposition and organ growth. Thus, enhanced DNA accretion by IGF-I was primarily responsible for stimulating muscle growth. In turn, secondary effects on body composition were incurred that likely reflect the impact of muscle mass on whole body metabolism.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12528713     DOI: 10.1096/fj.02-0289fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

1.  Ribosome abundance regulates the recovery of skeletal muscle protein mass upon recuperation from postnatal undernutrition in mice.

Authors:  Marta L Fiorotto; Teresa A Davis; Horacio A Sosa; Carolina Villegas-Montoya; Irma Estrada; Ryan Fleischmann
Journal:  J Physiol       Date:  2014-09-19       Impact factor: 5.182

2.  The effects of Capn1 gene inactivation on skeletal muscle growth, development, and atrophy, and the compensatory role of other proteolytic systems.

Authors:  C M Kemp; W T Oliver; T L Wheeler; A H Chishti; M Koohmaraie
Journal:  J Anim Sci       Date:  2013-07       Impact factor: 3.159

3.  Leucine Supplementation Does Not Restore Diminished Skeletal Muscle Satellite Cell Abundance and Myonuclear Accretion When Protein Intake Is Limiting in Neonatal Pigs.

Authors:  Marko Rudar; Daniel A Columbus; Julia Steinhoff-Wagner; Agus Suryawan; Hanh V Nguyen; Ryan Fleischmann; Teresa A Davis; Marta L Fiorotto
Journal:  J Nutr       Date:  2020-01-01       Impact factor: 4.798

Review 4.  Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass.

Authors:  Marco Cassano; Mattia Quattrocelli; Stefania Crippa; Ilaria Perini; Flavio Ronzoni; Maurilio Sampaolesi
Journal:  J Muscle Res Cell Motil       Date:  2010-03-02       Impact factor: 2.698

5.  Molecular and biochemical regulation of skeletal muscle metabolism.

Authors:  Morgan D Zumbaugh; Sally E Johnson; Tim H Shi; David E Gerrard
Journal:  J Anim Sci       Date:  2022-08-01       Impact factor: 3.338

6.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

7.  Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models.

Authors:  Stefano Schiaffino; Cristina Mammucari
Journal:  Skelet Muscle       Date:  2011-01-24       Impact factor: 4.912

8.  Integrative Analyses of miRNA-mRNA Interactions Reveal let-7b, miR-128 and MAPK Pathway Involvement in Muscle Mass Loss in Sex-Linked Dwarf Chickens.

Authors:  Wen Luo; Shumao Lin; Guihuan Li; Qinghua Nie; Xiquan Zhang
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

9.  Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.

Authors:  Rui Hu; Zhisheng Wang; Quanhui Peng; Huawei Zou; Hongze Wang; Xiaoqiang Yu; Xiaoping Jing; Yixin Wang; Binghai Cao; Shanke Bao; Wenhua Zhang; Suonan Zhao; Hanzhong Ji; Xiangying Kong; Quanxi Niu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

10.  Incorporation of a skeletal muscle-specific enhancer in the regulatory region of Igf1 upregulates IGF1 expression and induces skeletal muscle hypertrophy.

Authors:  Yunlong Zou; Yanjun Dong; Qingyong Meng; Yaofeng Zhao; Ning Li
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.